Log In
Sign Up
Find a Lawyer
Ask a Lawyer
Research the Law
Law Schools
Laws & Regs
Newsletters
Marketing Solutions
Justia Connect
Pro Membership
Practice Membership
Public Membership
Justia Lawyer Directory
Platinum Placements
Gold Placements
Justia Elevate
SEO
Websites
Blogs
Justia Amplify
PPC Management
Google Business Profile
Social Media
Justia Onward Blog
Justia
Patents
Patents Assigned to NEUROTROPE BIOSCIENCE, INC.
Patents Assigned to NEUROTROPE BIOSCIENCE, INC.
METHODS AND COMPOSITIONS FOR TREATMENT OF ALZHEIMER'S DISEASE AND OTHER NEURODEGENERATIVE DISORDERS
Publication number:
20200323817
Abstract:
A method for treating Alzheimer's disease (AD) by administering to an AD patient a PKC activator, such as a bryostatin-1, without administering a NMDA receptor antagonist, such as memantine.
Type:
Application
Filed:
June 28, 2020
Publication date:
October 15, 2020
Applicant:
NEUROTROPE BIOSCIENCE, INC.
Inventor:
Daniel L. Alkon